pandemic

AMA Update 28: Pausing the J&J vaccine: liaison shares what physicians need to know

Friend of the show, Dr. Sandra Fryhofer—the AMA liaison to the CDC’s Advisory Committee on Immunization Practices and the AMA’s representative on the COVID-19 vaccine work group—joins us for a quick and comprehensive look at the emerging details regarding the J&J/Janssen COVID-19 vaccine.

Read More

AMA Update 26: Potential fourth surge and other COVID questions

Harris Pastides, PhD, MPH, an epidemiologist and AMA Trustee, discusses the recent uptick in COVID-19 cases and possible quick-response approaches to curb the spread. He also shares insights from his role on the North and South Carolina Governors’ task force for future pandemic preparedness and stresses the importance of getting shots into arms.

Read More

AMA Update 22: Advocacy issues that matter to physicians

A discussion with Todd Askew, the AMA’s Senior Vice President of Advocacy in Washington, D.C., about the financial impact of the pandemic on physician practices and the Medicare sequester cut. Also breaking down finer points related to the American Rescue Plan Act and the Provider Relief Fund.

Read More

AMA Update 21: Dr. Mira Irons on concerns of outdated AstraZeneca vaccine data

Discussion with AMA’s Chief Health and Science Officer, Dr. Mira Irons, to review COVID-19 numbers and trending topics related to the pandemic over the past week. Also covering AstraZeneca news, importance of risk mitigation for spring and summer, as well as state-by-state vaccine availability and rollouts. 

Read More